Page 28 - Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<h4><i>The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026</i></h4><p/>SEATTLE, USA - News Direct - 04 January 2024 - <a href="https://www.agcbio.com/"><b>AGC</b> Biologics</a>, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.

The report states that the burgeoning middle class in India is playing a pivotal role in catalysing a significant surge in healthcare expenditure 

AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan

SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO),

WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO) specialising in vaccines, has been awarded the title of &#39;Best Vaccine CMO of the Year&#39; for the second consecutive year at the 2023 Asia-Pacific Vaccine Excellence Awards (AVEA). Click to read more...